KOURTNEY SABALA: Open Payments
NPI 1043760960 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 21 payments from 7 companies in 2025. Trend: 2023 $453 · 2024 $2,100 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $157 |
| ABBVIE INC. | 5 | $89 |
| Biogen, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, ABILIFY MAINTENA, ZURZUVAE, SPRAVATO, ARISTADA, UZEDY, Auvelity.
Industry payments across NE — which companies pay providers there.
